Citation Impact
Citing Papers
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia
2006
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?
2005
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients
2003
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia
1996
Heparin-Induced Thrombocytopenia
1998
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
2003
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Antiphospholipid Syndrome and Heparin-induced Thrombocytopenia: Update on Similarities and Differences
2000
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
Mammalian GPI proteins: sorting, membrane residence and functions
1997
Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces
2004 StandoutNobel
Anti‐CD36 antibodies in thrombotic thrombocytopenic purpura
1994
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
1999
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Platelet Activation and Atherothrombosis
2007 Standout
A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis
2016
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
2008 StandoutNobel
Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin
2002
Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis
2005
Immune Thrombocytopenic Purpura
2002 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
The Antiphospholipid Syndrome
2002 Standout
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation
2005
A Highly Selective Fluorescent Probe for Thiophenols
2007
Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes
1996
Heparin and Low-Molecular-Weight Heparin
1998
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Modulation of monocyte-endothelial cell interactions by platelet microparticles.
1998
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
2010
Simple Biosensor with High Selectivity and Sensitivity: Thiol‐Specific Biomolecular Probing and Intracellular Imaging by AIE Fluorogen on a TLC Plate through a Thiol–Ene Click Mechanism
2010
Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy
2000
Heparin‐associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan
1992
A 14-year study of heparin-induced thrombocytopenia
1996 Standout
Safety of Warfarin Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Advances in the diagnosis of idiopathic thrombocytopenic purpura
2000
The Pathophysiology of Heparin-Induced Thrombocytopenia
2005
Heparin-induced thrombocytopenia in hemodialysis patients
1996
Disseminated Intravascular Coagulation
1999 Standout
Heparin
1991
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia
1999
Recurrent miscarriage
2006 Standout
New sensing mechanisms for design of fluorescent chemosensors emerging in recent years
2011 Standout
Aggregation-induced emission
2011 Standout
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia
1997
Circulating microparticles: pathophysiology and clinical implications
2006
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia
2016
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
A prospective study of protein‐specific assays used to investigate idiopathic thrombocytopenic purpura
1999
Heparin-associated Thrombocytopenia: A Critical Review and Pooled Analysis
1993
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
2019
Hierarchical Assembly of Model Cell Surfaces: Synthesis of Mucin Mimetic Polymers and Their Display on Supported Bilayers
2007 StandoutNobel
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
2001
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
1998
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies
2000
Studies of Fibrinogen Binding to Platelets by Flow Cytometry: An Improved Method for Studies of Platelet Activation
1992 StandoutNobel
Reversal of Heparin Anticoagulation by Recombinant Platelet Factor 4 in Humans
1995
Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4–heparin antibodies to platelets and the resultant platelet activation
2000
Heparin-induced Thrombocytopenia: Towards Consensus
1998
Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies
2004
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Elucidation of N-Glycosylation Sites on Human Platelet Proteins
2005
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
1994
Differential Effects of Anticoagulants on the Activation of Platelets Ex Vivo
1997
Synthetic Analogues of Glycosylphosphatidylinositol-Anchored Proteins and Their Behavior in Supported Lipid Bilayers
2007 StandoutNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
FcγRIIA H/R131 Polymorphism, Subclass-Specific IgG Anti-Heparin/Platelet Factor 4 Antibodies and Clinical Course in Patients With Heparin-Induced Thrombocytopenia and Thrombosis
1997
Homogeneous Glycopeptides and Glycoproteins for Biological Investigation
2002 StandoutNobel
Circulating Procoagulant Microparticles in Women with Unexplained Pregnancy Loss: a New Insight
2001
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Defining an Antigenic Epitope on Platelet Factor 4 Associated With Heparin-Induced Thrombocytopenia
1998
A chemical approach to unraveling the biological function of the glycosylphosphatidylinositol anchor
2007 StandoutNobel
COAGULATION DISORDERS IN CANCER
1996
First Workshop for Detection of Heparin-induced Antibodies: Validation of the Heparin-induced Platelet-activation Test (HIPA) in Comparison with a PF4/Heparin ELISA
1999
Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia
1996
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Low-Molecular-Weight Heparins
1997 Standout
In Vitro Selection of Functional Nucleic Acids
1999 StandoutNobel
The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for Proteins
2008 StandoutNobel
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
2003
Antibodies to Macromolecular Platelet Factor 4-Heparin Complexes in Heparin-induced Thrombocytopenia: a Study of 44 Cases
1995
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Synthesis of Lipidated Green Fluorescent Protein and Its Incorporation in Supported Lipid Bilayers
2005 StandoutNobel
In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits
1993
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis
2000
Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG/serum and other IgG platelet agonists: a comparison with standard platelet agonists
1999
Chemical Glycoproteomics
2016 StandoutNobel
Works of TE Warkentin being referenced
Heparin-induced thrombocytopenia
2013
Heparin-Induced Thrombocytopenia
1989
Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia
1994
Multimerin: a series of large disulfide-linked multimeric proteins within platelets
1991
Gova/b alloantigen system on human platelets
1990
Investigation of the mechanisms of monoclonal antibody-induced platelet activation
1991
Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4
1994
Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles
1992
Characterization and localization of the Gova/b alloantigens to the glycosylphosphatidylinositol-anchored protein CDw109 on human platelets
1995
Investigation of the mechanisms of monoclonal antibody-induced platelet activation
1991
Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles
1992